Skip to main content

CORRECTION article

Front. Pharmacol., 10 November 2022
Sec. Gastrointestinal and Hepatic Pharmacology
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1073445

Corrigendum: Adenosine receptor stimulation by polydeoxyribonucleotide improves tissue repair and symptomology in experimental colitis

This article is a correction to:

  1. Adenosine Receptor Stimulation by Polydeoxyribonucleotide Improves Tissue Repair and Symptomology in Experimental Colitis

    1. Read original article
Giovanni PallioGiovanni Pallio1Alessandra Bitto Alessandra Bitto1*Gabriele PizzinoGabriele Pizzino1Federica GalfoFederica Galfo1Natasha IrreraNatasha Irrera1Francesco SquadritoFrancesco Squadrito1Giovanni SquadritoGiovanni Squadrito2Socrate PallioSocrate Pallio1Giuseppe P. AnastasiGiuseppe P. Anastasi3Giuseppina CutroneoGiuseppina Cutroneo2Antonio MacrìAntonio Macrì2Domenica AltavillaDomenica Altavilla3
  • 1Section of Pharmacology, Department of Clinical and Experimental Medicine, Medical School, University of Messina, Messina, Italy
  • 2Department of Human Pathology, University of Messina, Messina, Italy
  • 3Department of Biomedical Sciences and Morphological and Functional Images, University of Messina, Messina, Italy

A Corrigendum on
Adenosine receptor stimulation by polydeoxyribonucleotide improves tissue repair and symptomology in experimental colitis

by Pallio G, Bitto A, Pizzino G, Galfo F, Irrera N, Squadrito F, Squadrito G, Pallio S, Anastasi GP, Cutroneo G, Macrì A and Altavilla D (2016). Front. Pharmacol. 7:273. doi: 10.3389/fphar.2016.00273

In the published article, the Conflict of Interest statement was incorrectly filed. The correct Conflict of Interest statement appears below.

“Author FS has received research support from Mastelli for work on polydeoxyribonucleotide. Authors FS, AB and DA are co-inventors on a patent describing therapeutic polydeoxyribonucleotide activity in chronic intestinal disease.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: colitis, A2A agonist, PDRN, inflammation, apoptosis

Citation: Pallio G, Bitto A, Pizzino G, Galfo F, Irrera N, Squadrito F, Squadrito G, Pallio S, Anastasi GP, Cutroneo G, Macrì A and Altavilla D (2022) Corrigendum: Adenosine receptor stimulation by polydeoxyribonucleotide improves tissue repair and symptomology in experimental colitis. Front. Pharmacol. 13:1073445. doi: 10.3389/fphar.2022.1073445

Received: 18 October 2022; Accepted: 19 October 2022;
Published: 10 November 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Lausanne, Switzerland

Copyright © 2022 Pallio, Bitto, Pizzino, Galfo, Irrera, Squadrito, Squadrito, Pallio, Anastasi, Cutroneo, Macrì and Altavilla. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Alessandra Bitto, abitto@unime.it

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.